You do not have the latest flash plugin or you have disabled javascript.

Pharmaceuticals Blog

FDA sends harsh warning letter concerning Avandia studies

April 9th, 2008 by Todd Hageman

The Food and Drug Administration recently sent a harsh warning letter to GlaxoSmithKline, the maker of the diabetes drug Avandia. According to Pharmalot, Glaxo failed to include nine post-marketing studies in a mandatory report to the FDA. A Glaxo spokesperson is claiming this to be an “inadvertent omission.”

A few months ago, the FDA ordered Glaxo to put stronger “black box” warnings on the packaging. 

If you or someone you know has been hurt as a result of taking a dangerous medication, contact Todd Hageman toll free at 1-877-767-3108.

 

Simon Passanante is nationally recognized as a result of its successful handling of jury trials on a wide variety of cases. You are invited to view the firm’s notable verdicts and settlements. Much of the information on this site is presented through videos. Other pages of this site concern Simon Passanante’s honors and awards, testimonials from clients and referring attorneys, and safety information. Our employee directory is here. If you have any questions for us, email us. See this page for important legal disclosures and to learn about contingent fees. For updates regarding Simon Passanante, we invite you to explore our law blogs.

Simon Passanante PC

701 Market Street

Suite 1450

St. Louis, Missouri 63101

Toll Free: 877.767.3108

Fax: 314.241.2029

Close
E-mail It